Courts Should Kill Trump's Pricey '2-for-1' Deregulation Order
Courts Should Kill Trump's Pricey '2-for-1' Deregulation Order, op-ed by Dan Farber
Read PDF
Author(s): Daniel Farber
Joint Letter to OIRA re Guidance to Agencies on Implementation of 2-for-1 Deregulatory Executive Order
Joint Letter to OIRA from 31 CPR Member Scholars and Staff re Guidance to Agencies on Implementation of 2-for-1 Deregulatory Executive Order
Read PDF
Federal Proposal Would Jeopardize Public Safety
Federal Proposal Would Jeopardize Public Safety, op-ed by Thomas McGarity
Read PDF
Author(s): Thomas McGarity
Lisa Heinzerling's testimony before the Senate Commerce Committee on the importance of regulatory safeguards.
Lisa Heinzerling's February 1, 2017, testimony before the Senate Commerce Committee on the importance of regulatory safeguards.
Read PDF
Author(s): Lisa Heinzerling
Quietly Passed Act Favors Profits Over Health and Safety
Quietly Passed Act Favors Profits Over Health and Safety, op-ed by Thomas McGarity
Read PDF
Author(s): Thomas McGarity
Beware Compounded Drugs -- Especially Under Trump’s FDA
Writing for The American Prospect, Rena Steinzor observes that a burgeoning and little-regulated private industry that specially mixes drugs at so-called compounding pharmacies poses a public-health hazard that the Trump administration will only make worse.
Read PDF
Author(s): Rena Steinzor